Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-11-15
2005-11-15
Huang, Evelyn Mei (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S232800, C546S085000, C546S086000, C546S087000, C544S126000
Reexamination Certificate
active
06964970
ABSTRACT:
Compounds of the formula (I) are disclosed which are Fab I inhibitors and are useful in the treatment bacterial infections:wherein:R1is Ar or Het;R2is H, C1-6alkyl or Ar-C0-6alkyl;X is H, C1-4alkyl, OR′, SR′, C1-4alkylsulfonyl, C1-4alkylsulfoxyl, CN, N(R′)2, CH2N(R′)2, NO2, CF3, CO2R′, CON(R′)2, COR′, NR′C(O)R′, F, Cl, Br, I, or CF3S(O)r—;R′ is H, C1-6alkyl or Ar-C0-6alkyl; andr is 0, 1 or 2;or a pharmaceutically acceptable salt thereof.
REFERENCES:
patent: 3828068 (1974-08-01), Minieri
patent: 4154943 (1979-05-01), Kuehne
patent: 4977159 (1990-12-01), Sevrin et al.
patent: 5614551 (1997-03-01), Dick et al.
patent: 5624941 (1997-04-01), Barth et al.
patent: 5932743 (1999-08-01), Collini et al.
patent: 5985867 (1999-11-01), Rodgers et al.
patent: 6346391 (2002-02-01), Oethinger et al.
patent: 6372752 (2002-04-01), Staveski et al.
patent: 6451816 (2002-09-01), Biedermann et al.
patent: 6469046 (2002-10-01), Daines et al.
patent: 6503903 (2003-01-01), Miller et al.
patent: 6503908 (2003-01-01), Maw
patent: 6559172 (2003-05-01), Heerding et al.
patent: 6573272 (2003-06-01), Miller et al.
patent: WO 98/57952 (1998-12-01), None
patent: 21069 (1991-11-01), None
patent: WO 95/18619 (1995-07-01), None
patent: WO 96/00730 (1996-01-01), None
patent: WO 97/48696 (1997-12-01), None
patent: WO 01/26652 (2001-04-01), None
patent: WO 01/26654 (2001-04-01), None
patent: WO 01/27103 (2001-04-01), None
patent: WO 01/48248 (2001-07-01), None
patent: WO 02/42273 (2002-05-01), None
patent: WO 02/48097 (2002-06-01), None
Abou-Gharbia et al., “Psychotropic Agents: Synthesis and Antipysychotic Activity of Substituted B-Carbolines,” J. Med. Chem., 30(6):1100-1115 (1987).
Ahsan et al., “Reserpine Anlogues: Synthesis of B-Carboline Derivatives,” J. Chem. Soc., pp. 3928-3920 (1963).
Database Crossfire Beilstein, 1966, Database accession No. 2819049, 2819050, XP002216033.
Database CA on STN, AN 7:66733, Rosenmund et al., “Chemistry of indole II . . . ,”Chem Ber. 103(2):496-509 (1970).
Database CAOLD on STN, AN CA51:10524d, Hellman et al., “N-Mannich bases (VI) condensation . . . ,”Direct Submission(1953).
Database CAPLUS on STN, An 1977:439214, Misztal et al., “Synthesis and pharmacologic properties of pyridoyl . . . ,”Arch Immuno Ther Exp. 24(6):851-862 (1976).
Himmer et al., “Synthesis and Antibacterial in Vitro Activity of Novel Analogues of Nematophin,” Bioorganic & Medicinal Chemistry Letters, 8(15):2045-2050 (Aug. 1998).
Jianxiong et al., “Synthesis and Antistaphylococcal Activity of Nematophin and Its Analogs,” Bioorganic & Medicinal Chemistry Letters, Oxford, GB, 7(10):1349-1352, (May 20, 1977) XP004136332.
Miller et al., Discovery of Aminopyridine-Based Inhibitors of Bacterial Enoyl-ACP Reductase (FABI); J. Med. Chem. 2002, vol. 45, pps. 3246-3256.
Misztal et al., “Synthesis and Pharmacologic Properties of Pyridol Derivatives of 3-Methylaminoindole 2-Methyltryptamine and Isotryptamine,” Archivum Immnologiae et Therapiae Experimentalis, 24(6):851-852 (1976).
Pachter et al., “The Chemistry of Hortiamine and 6-Methoxyhetsinine,” J. Amer. Chem., 83:635-642 (1961).
Rehse et al., “Dopaminanaloge 1,2,3,4-Tetrahydro-B-Carboline,” Arch. Pharm., 311(1):11-18 (1978).
Shoji et al., “Two Novel Alkaloids from Evodia Rutaecarpa,” J. Natural Products, 52(5):1160-1162 (1989).
Hungarian Novelty Search Report dated Jun. 6, 2003.
Miller William H.
Newlander Kenneth A.
Seefeld Mark
Affinium Pharmaceuticals, Inc.
Foley & Hoag LLP
Huang Evelyn Mei
LandOfFree
Antibacterial compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibacterial compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibacterial compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3499920